Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944]

IF 9.1 2区医学 Q1 PHARMACOLOGY & PHARMACY

Pharmacological research Pub Date : 2024-11-01 DOI:10.1016/j.phrs.2024.107463

Delong Chen , Zhen Ye , Chao Wang , Qingqing Wang , Haibin Wang , Vincent Kuek , Ziyi Wang , Heng Qiu , Jinbo Yuan , Jacob Kenny , Fan Yang , Jianbo He , Yun Liu , Gang Wang , Meng Zhang , Gangyu Zhang , Junjian Wang , Peng Chen , Jiake Xu

引用次数: 0

查看原文本刊更多论文

Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation" [Pharmacol. Res. 159 (2020) 104944] 的更正。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacological research 医学-药学

CiteScore

18.70

自引率

3.20%

发文量

491

审稿时长

8 days

期刊介绍： Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. Pharmacological research publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.